Truvestments Capital LLC Acquires Shares of 20,227 The Clorox Company $CLX

Key Points

• Truvestments Capital LLC has acquired a new stake in The Clorox Company, purchasing approximately 20,227 shares valued at $2.98 million.
• Clorox recently disclosed a quarterly dividend increase to $1.24 per share, with an annualized yield of 4.2%.
• Analysts have mixed views on Clorox, with one Buy rating, eight Hold ratings, and three Sell ratings, projecting an average target price of $143.36.

Truvestments Capital LLC acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 20,227 shares of the company's stock, valued at approximately $2,978,000.

Several other institutional investors also recently bought and sold shares of the company. B. Metzler seel. Sohn & Co. AG increased its holdings in Clorox by 107.9% during the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 6,105 shares of the company's stock worth $899,000 after purchasing an additional 3,169 shares during the period. Ieq Capital LLC increased its holdings in shares of Clorox by 236.4% in the 1st quarter. Ieq Capital LLC now owns 19,763 shares of the company's stock valued at $2,910,000 after acquiring an additional 13,889 shares during the period. FORA Capital LLC purchased a new position in shares of Clorox in the 1st quarter valued at $2,006,000. Campbell & CO Investment Adviser LLC increased its holdings in shares of Clorox by 318.5% in the 1st quarter. Campbell & CO Investment Adviser LLC now owns 37,624 shares of the company's stock valued at $5,540,000 after acquiring an additional 28,633 shares during the period. Finally, Quantitative Investment Management LLC increased its holdings in shares of Clorox by 868.9% in the 1st quarter. Quantitative Investment Management LLC now owns 23,747 shares of the company's stock valued at $3,496,000 after acquiring an additional 21,296 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.2%

Shares of Clorox stock traded up $0.27 during trading on Friday, reaching $118.21. The company's stock had a trading volume of 1,815,992 shares, compared to its average volume of 1,831,786. The company has a 50-day simple moving average of $123.93 and a two-hundred day simple moving average of $134.27. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a market cap of $14.46 billion, a price-to-earnings ratio of 18.13, a P/E/G ratio of 0.94 and a beta of 0.49.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same quarter in the previous year, the firm posted $1.82 EPS. The firm's revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th were given a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 4.2%. This is an increase from Clorox's previous quarterly dividend of $1.22. Clorox's payout ratio is presently 76.07%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of analyst reports. Morgan Stanley cut their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. JPMorgan Chase & Co. cut their price target on Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Jefferies Financial Group cut their price target on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Finally, UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Reduce" and an average target price of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.